5 results on '"Riccardo, Bartoletti"'
Search Results
2. Fluorodeoxyglucose positron emission tomography may aid the diagnosis of aggressive primary prostate cancer: A case series study
- Author
-
Andrea Bongini, Carlo Magno, T. Tony Cai, Riccardo Bartoletti, and E. Meliani
- Subjects
Cancer Research ,medicine.medical_specialty ,positron emission tomography ,Prostate biopsy ,medicine.medical_treatment ,Urology ,cancer metabolism ,metabolism/radionuclide imaging ,Humans ,Positron-Emission Tomography ,prostate specific antigen ,Asymptomatic ,Prostate cancer ,Prostate ,medicine ,medicine.diagnostic_test ,Prostatectomy ,business.industry ,Cancer ,Articles ,prostate cancer ,medicine.disease ,Surgery ,Radiation therapy ,Prostate-specific antigen ,medicine.anatomical_structure ,Oncology ,high-risk prostate cancer ,medicine.symptom ,business - Abstract
Recent evidence has shown that positive results may be observed for fluorodeoxyglucose-positron emission tomography (FDG-PET) in undifferentiated, biologically aggressive and metastatic tumors. The present study describes a case series of six patients with normal prostate-specific antigen (PSA) serum levels who underwent FDG-PET due to other causes. Positive PET results were observed at the prostate and the patients were subsequently diagnosed with high-risk prostate cancer. Clinical, anamnestic, laboratory and instrumental data were collected from six asymptomatic patients with total serum PSA levels of
- Published
- 2013
3. Human papillomavirus and non-muscle invasive urothelial bladder cancer: Potential relationship from a pilot study
- Author
-
Gabriella Nesi, Francesca Meacci, T. Tony Cai, Gianni Malossini, Pierangelo Geppetti, Sandra Mazzoli, and Riccardo Bartoletti
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Pathology ,Pilot Projects ,Urine ,Alphapapillomavirus ,Gastroenterology ,Risk Factors ,Internal medicine ,medicine ,Humans ,Neoplasm Invasiveness ,Prospective cohort study ,Pathological ,Aged ,Aged, 80 and over ,Bladder cancer ,business.industry ,Carcinoma ,Papillomavirus Infections ,Case-control study ,HPV infection ,Cancer ,General Medicine ,Middle Aged ,medicine.disease ,female genital diseases and pregnancy complications ,Transitional cell carcinoma ,Urinary Bladder Neoplasms ,Oncology ,Case-Control Studies ,DNA, Viral ,Female ,Urothelium ,business - Abstract
The relationship between urothelial bladder cancer and high-risk human papillomaviruses (HR-HPV) is still a poorly understood entity, even if some studies have supposed a probably correlation. The aim of the present study was to assess the potential relationship between the presence of HR-HPV and non-muscle invasive urothelial bladder cancers (NMIBC). One hundred and thirty-seven subjects (78 patients affected by NMIBC and 59 controls) were recruited in this prospective study. HR-HPV DNA was evaluated both in urine and tumour tissues. Data from patients were compared with data from controls. The relationship between patients and controls, in terms of HR-HPV presence was performed. The relationship between all pathological data and HR-HPV presence in patient group was carried out. HR-HPV DNA in tissue was found in 27 of 78 (34.6%) tumour samples and in 6 of 59 (10.1%) specimens from TUR-P, with a statistically significant difference (p=0.0009; dF=1; χ2=10.98). HR-HPV DNA in urine was found in 36 of 78 (46.1%) samples obtained from patients, whereas in only 8 of 59 (13.5%) samples from controls (p
- Published
- 2011
4. E-cadherin mRNA expression analysis in evaluating the natural history of urothelial bladder cell carcinoma: Results from a long-term follow-up study
- Author
-
Nicola Mondaini, T. Tony Cai, Riccardo Bartoletti, Ilaria Taddei, Gabriella Nesi, M. Piazzini, Beatrice Detti, Maurizio Dal Canto, and Iacopo Sardi
- Subjects
Male ,Oncology ,Cancer Research ,medicine.medical_specialty ,Pathology ,Internal medicine ,Carcinoma ,medicine ,Humans ,RNA, Messenger ,Urothelium ,Survival rate ,Survival analysis ,Aged ,Urinary bladder ,Bladder cancer ,business.industry ,Cancer ,General Medicine ,Cadherins ,Prognosis ,medicine.disease ,Molecular medicine ,Survival Rate ,medicine.anatomical_structure ,Urinary Bladder Neoplasms ,Disease Progression ,Female ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies - Abstract
Many studies have indicated that the E-cadherin (E-CAD) expression loss is associated with the loss of cellular differentiation and increased cellular invasiveness and can be correlated with poor prognosis in urothelial carcinoma (UC) of the urinary bladder. The aim of this study was to define the role of E-CAD mRNA expression on recurrence, progression and survival in UC of the urinary bladder over a long follow-up period. From 30 patients with bladder UC, enrolled in our previous study, 27 were selected for this study. All patients were re-analyzed in terms of clinical and tumor characteristics, tumor pathological analysis and tumor E-CAD mRNA expression. The data were correlated to 12-year follow-up results. Significant correlations between stage (p=0.002), grade (p=0.008) and E-CAD mRNA expression were reported. E-CAD did not show any correlation in predicting recurrence or progression in bladder UC. The survival analysis demonstrated a significant relationship (p=0.019) between patients with expressed E-CAD mRNA levels and cancer-specific survival. Multivariate analysis demonstrated that expression of E-CAD mRNA levels is an independent prognostic factor in terms of cancer-specific survival in UC of the urinary bladder (p=0.002). Our study is the first to demonstrate that mRNA extraction and Northen blot analysis is to be considered a reliable method to evaluate E-CAD mRNA levels for predicting survival rate in patients affected by urothelial bladder cancers. We stress that a long follow-up period is needed to evaluate the role of molecular factors in predicting prognosis in patients affected by bladder UC.
- Published
- 2007
5. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: Recurrence rate and survival in a group of patients at 10 years follow-up
- Author
-
Riccardo Bartoletti, Gabriella Nesi, Edoardo Margallo, Michelangelo Rizzo, T. Tony Cai, and Gianluca Giubilei
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Pathology ,Urology ,Biology ,Flow cytometry ,medicine ,Humans ,Stage (cooking) ,Aged ,Image Cytometry ,Carcinoma, Transitional Cell ,Ploidies ,Bladder cancer ,medicine.diagnostic_test ,Cancer ,DNA, Neoplasm ,General Medicine ,Middle Aged ,Cell cycle ,Prognosis ,medicine.disease ,Nuclear DNA ,Treatment Outcome ,Transitional cell carcinoma ,Urinary Bladder Neoplasms ,Oncology ,Female ,Neoplasm Recurrence, Local ,Cytometry ,Follow-Up Studies - Abstract
Many studies have indicated that nuclear DNA content evaluation can be used to predict biological behavior of transitional cell carcinoma (TCC) of the bladder. Some authors also indicated that static cytometry is more useful in DNA content analysis than flow cytometry. The aim of the present study was to evaluate the prognostic significance of DNA ploidy in TCC of the bladder, performed by using static cytometry with an image analyzer, and monitoring patients at 10 years follow-up. Thirty-one consecutive patients underwent transurethral or open surgery for bladder tumors, and neoplastic tissue samples taken from each patient were imprinted on glass slides and sent for histopathological and DNA content evaluation. DNA ploidy evaluation was performed using a CAS 200 image analyzer. Nuclear DNA content evaluation was compared to patient follow-up on recurrence, progression or survival performed 10 years after surgery. Pathological evaluation demonstrated the presence of superficial TCC in 23 patients, while 8 had an invasive bladder tumor. Twenty-nine tumor samples were adequate for DNA content measurement, with 13 showing diploid DNA content and 16 with aneuploid DNA content. At 10 years follow-up, all patients with aneuploid DNA content demonstrated a lower survival time (p=0.049) and higher recurrence rate (p=0.0346). A log-rank test demonstrated that stage, grade and nuclear DNA content are the most useful prognostic parameters for predicting the biological behavior of TCC of the bladder. These results confirm that static cytometry is a good and reliable method to evaluate DNA tumor content and considered a useful prognostic parameter for predicting recurrence rate, disease progression or survival in patients affected by bladder tumors.
- Published
- 2006
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.